Skip to main content
Premium Trial:

Request an Annual Quote

TIGR-Led Group Sequences, Compares Campylobacter Strains

NEW YORK, Jan. 4 (GenomeWeb News) - A group led by researchers from The Institute for Genomic Research sequenced a strain of the bacterium Campylobacter jejuni, and nearly completed the sequences of three additional strains, TIGR said yesterday.


In an article published in the January 2005 issue of PLoS Biology, researchers published the new sequences and compared them with that of a laboratory strain of C. jejuni sequenced in 2000. The comparative studies provided insight into why some strains of Campylobacter are more virulent than others, TIGR said.


According to a TIGR spokesperson, the group has fully sequenced to closure the RM1221 strain of C. jejuni, which was isolated from chicken skin and is known to efficiently colonize chicken digestive tracts.


The group has also sequenced to 8x coverage or higher the genomes of a multidrug-resistant strain of C. coli isolated from a chicken; a C. lari strain associated with human illness; and a C. upsaliensis strain isolated from a child with Guillain-Barre syndrome, TIGR said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.